Dr. A. V. Rama Rao had an impressive career as a scientist and institutional builder in India. He obtained degrees in chemistry and chemical technology before earning his Ph.D. He conducted post-doctoral studies with Nobel Laureate E.J. Corey at Harvard University. After returning to India, he established a school of excellence for synthesis of biofunctional molecules. He later served as director of the Indian Institute of Chemical Technology, managing over 1,400 employees including 500 scientists.
Bharat Biotech is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella and headquartered in Hyderabad, India. It has developed several innovative vaccines through world-class research and owns over 160 global patents. Recently, it partnered with ICMR to develop India's first indigenous COVID-19 vaccine called Covaxin. The company aims to solve health challenges in developing countries by developing affordable vaccines and therapeutics.
This document summarizes the top 10 pharmaceutical companies in India by market capitalization in June 2020. It provides brief histories and descriptions of each company, including their founding dates and locations, major products and therapeutic areas, and growth over time to become leaders in the Indian pharmaceutical market. The companies discussed are Sun Pharmaceuticals, Dr. Reddy's Laboratories, Divi's Laboratories, Cipla, Aurobindo Pharma, Torrent Pharmaceuticals, Lupin Ltd, Zydus Cadila Healthcare, Abbott India, and Alkem Laboratories.
Kiran Mazumdar Shaw is an Indian businesswoman and the founder of Biocon, India's largest biotechnology company. She has over 40 years of experience in the biotechnology industry. Some key points:
- Founded Biocon in 1978 with just Rs. 10,000 in capital. Within a year, Biocon became the first Indian company to export enzymes to the US and Europe.
- Under her leadership, Biocon has become a billion dollar company and India's largest biotech firm. It develops biosimilar drugs and is a leading manufacturer of insulin.
- She is considered a pioneer in the Indian biotech sector and has helped establish several other biotech firms. Through her philanthropic foundation,
Philanthropic Activities for all sorts of IssuesYosef Meystel
Here are a few examples of the sectors where philanthropic activities take place and the names of non-profits that work trying to provide solutions for the issues that rise and their corresponding sectors .
The document discusses the mobile telecommunication industry in Sri Lanka and how the business environment affects it. There are 5 main mobile operators in Sri Lanka. The key factors that influence the industry are the demographic environment like population, age, jobs which impact usage; political and legal factors like taxes and regulations; the economic environment like GDP and unemployment; technological advances in areas like 4G; and natural environment issues around installations. The socio-cultural environment like changing lifestyles also drives changes in the industry.
Sunil mittal case study (developed by ranjan shetty)ranjanshetty
This document provides an overview of Sunil Bharti Mittal's leadership and ability to inspire others through building Bharti Airtel into a major telecom company in India. It describes how he started small businesses and recognized opportunities in the growing telecom sector. Through strategic partnerships and an entrepreneurial mindset, he expanded mobile services across India. The document highlights how he transitioned the company to be professionally managed while still providing entrepreneurial guidance as the company grew substantially.
This document provides an introduction to Sunil Bharti Mittal, an Indian businessman and founder of the Bharti Group. It outlines his educational background and describes his entrepreneurial ventures starting in 1976 with a bicycle parts business. A key turning point was winning a mobile phone license in 1992, leading to the formation of Bharti Cellular (now Bharti Airtel) in 1995. The document also discusses his expansion into sectors like telecom, retail, insurance, and philanthropy through the Bharti Foundation.
Sunil Bharti Mittal founded Bharti Group in 1976 and incorporated cellular operations as Bharti Tele-Ventures in 1995, launching mobile service in Delhi. Over time, Airtel expanded across India and internationally, becoming one of the largest mobile networks in the world operating in 20 countries across Asia and Africa. Airtel offers various mobile and fixed-line services including 4G, broadband, digital TV, Airtel Money mobile payments and more. The company's vision is to be the most loved brand enriching lives through digital solutions.
Bharat Biotech is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella and headquartered in Hyderabad, India. It has developed several innovative vaccines through world-class research and owns over 160 global patents. Recently, it partnered with ICMR to develop India's first indigenous COVID-19 vaccine called Covaxin. The company aims to solve health challenges in developing countries by developing affordable vaccines and therapeutics.
This document summarizes the top 10 pharmaceutical companies in India by market capitalization in June 2020. It provides brief histories and descriptions of each company, including their founding dates and locations, major products and therapeutic areas, and growth over time to become leaders in the Indian pharmaceutical market. The companies discussed are Sun Pharmaceuticals, Dr. Reddy's Laboratories, Divi's Laboratories, Cipla, Aurobindo Pharma, Torrent Pharmaceuticals, Lupin Ltd, Zydus Cadila Healthcare, Abbott India, and Alkem Laboratories.
Kiran Mazumdar Shaw is an Indian businesswoman and the founder of Biocon, India's largest biotechnology company. She has over 40 years of experience in the biotechnology industry. Some key points:
- Founded Biocon in 1978 with just Rs. 10,000 in capital. Within a year, Biocon became the first Indian company to export enzymes to the US and Europe.
- Under her leadership, Biocon has become a billion dollar company and India's largest biotech firm. It develops biosimilar drugs and is a leading manufacturer of insulin.
- She is considered a pioneer in the Indian biotech sector and has helped establish several other biotech firms. Through her philanthropic foundation,
Philanthropic Activities for all sorts of IssuesYosef Meystel
Here are a few examples of the sectors where philanthropic activities take place and the names of non-profits that work trying to provide solutions for the issues that rise and their corresponding sectors .
The document discusses the mobile telecommunication industry in Sri Lanka and how the business environment affects it. There are 5 main mobile operators in Sri Lanka. The key factors that influence the industry are the demographic environment like population, age, jobs which impact usage; political and legal factors like taxes and regulations; the economic environment like GDP and unemployment; technological advances in areas like 4G; and natural environment issues around installations. The socio-cultural environment like changing lifestyles also drives changes in the industry.
Sunil mittal case study (developed by ranjan shetty)ranjanshetty
This document provides an overview of Sunil Bharti Mittal's leadership and ability to inspire others through building Bharti Airtel into a major telecom company in India. It describes how he started small businesses and recognized opportunities in the growing telecom sector. Through strategic partnerships and an entrepreneurial mindset, he expanded mobile services across India. The document highlights how he transitioned the company to be professionally managed while still providing entrepreneurial guidance as the company grew substantially.
This document provides an introduction to Sunil Bharti Mittal, an Indian businessman and founder of the Bharti Group. It outlines his educational background and describes his entrepreneurial ventures starting in 1976 with a bicycle parts business. A key turning point was winning a mobile phone license in 1992, leading to the formation of Bharti Cellular (now Bharti Airtel) in 1995. The document also discusses his expansion into sectors like telecom, retail, insurance, and philanthropy through the Bharti Foundation.
Sunil Bharti Mittal founded Bharti Group in 1976 and incorporated cellular operations as Bharti Tele-Ventures in 1995, launching mobile service in Delhi. Over time, Airtel expanded across India and internationally, becoming one of the largest mobile networks in the world operating in 20 countries across Asia and Africa. Airtel offers various mobile and fixed-line services including 4G, broadband, digital TV, Airtel Money mobile payments and more. The company's vision is to be the most loved brand enriching lives through digital solutions.
Kiran Mazumdar-Shaw is an Indian entrepreneur who is the founder and chairperson of Biocon Limited, a biotechnology company based in Bangalore, India. She studied fermentation science and became the first woman to earn a degree in brewing. When she was unable to find work in her field in India due to gender discrimination, she started her own company Biocon in 1978 with just $500. Under her leadership, Biocon has grown into a major biotechnology company with over $800 million in annual revenue and has helped advance India's biotechnology industry. She has also established healthcare and education programs through the Biocon Foundation to benefit the underprivileged in India.
Kiran Mazumdar Shaw founded Biocon in 1978 in Bangalore as India's first biotech company. Starting with just two employees and operating out of a rented house garage with an initial capital of Rs. 10,000, Biocon focused initially on producing enzymes for use in industries like brewing. In the 1990s, Shaw pivoted Biocon's focus to biopharmaceuticals as its main business. Under her leadership, Biocon has grown to become a major biopharmaceutical company in India with facilities for producing insulin and statins. It has also expanded into areas like research services. Shaw's entrepreneurship and leadership has been instrumental in the growth of India's biotech sector.
Kiran Mazumdar Shaw is an Indian entrepreneur who founded Biocon, India's largest biotechnology company. After completing her education in zoology, she moved to Ireland and joined Biocon Biochemicals Limited as a trainee manager in 1978. In 1979, she founded Biocon India in collaboration with Biocon Biochemicals. Starting from her garage with only a few rupees, Biocon grew to become a major biopharmaceutical company under Kiran's leadership, pioneering the development of biosimilars and enzymes in India. Biocon now offers a range of biopharmaceuticals, enzymes, and clinical research services. Kiran is recognized for transforming Biocon into a globally recognized biotech company through her
Kallam Anji Reddy was an Indian industrialist and entrepreneur who founded Dr. Reddy's Laboratories in 1984. He transformed India's pharmaceutical industry from import-dependent to self-reliant and export-oriented. Reddy received many awards for his entrepreneurship and innovation. He was also a philanthropist who established the Dr. Reddy's Foundation for social development. Reddy passed away in 2013 at the age of 72, having made significant contributions to making medicines more affordable and accessible in India.
The Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of medicine in the UK. It is dominated by small and medium enterprises, though the largest 250 companies control 70% of the Indian market. India has gained prominence as the pharmacy of the world and biggest generic supplier due to its innovatively engineered generic drugs and active pharmaceutical ingredients. It accounts for around 30% of the $70-80 billion US generics market by volume and 10% by value.
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersDr. Pavan Kundur
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers,
Here i tried to compile all the future opportunities in biotechnology and microbiology
List of Nutraceutical Manufacturers in India | PharmaaddaAditiMehra14
The document lists the top 9 nutraceutical manufacturers in India and provides brief descriptions of each. It begins by defining nutraceuticals as products that provide both nutrition and medicinal benefits. Some of the largest manufacturers include Bionova Lifesciences, Chaitanya Agrobiotech Group, Lactonova Nutripharm, and Sydler. The industry in India is growing as multinational companies establish production facilities and Indian companies develop proprietary formulations to meet increasing demand for nutraceutical products.
Biotechnology has been used for thousands of years to produce foods and materials through fermentation and selective breeding. Modern biotechnology began in the 1970s with genetic engineering techniques allowing manipulation of organisms at the molecular level. While biotechnology has benefits like producing lifesaving drugs and drought-resistant crops, it also raises ethical issues regarding genetic modification and patenting of life. Governments aim to balance biotechnology development with responsible social and environmental oversight to ensure its safe and equitable progress.
Herbs, Herbal Drugs
Present Scope of Herbal Drug Industry
Scope of Herbal Drug Medicine and Industry
Indian Herbal Industry
International Scope of Herbal Medicines
World Wide Herbal Trade
Overview on plant based industries and research institutions in India
List of few herbal drug industries in India
List of few herbal research institution/ centres in India
General Introduction to Herbal Industry
Herbal drugs industry: Present scope and future prospects.
A brief account of plant based industries and institutions involved in work on medicinal and
aromatic plants in India.
The document discusses various topics related to biotechnology and biomedicine from a global perspective. It provides an overview of biotechnology applications, major biotechnology companies worldwide with the US dominating, and achievements in biotechnology in countries like India, China, and the US. It also summarizes developments in areas like medical biotechnology, biomedical engineering, genomics, tissue engineering, and future directions of biomedicine involving concepts like lab-on-a-chip and nanosensors.
The document discusses the evolution and growth of India's biotechnology sector. Some key points:
- India has emerged as a dominant player in biotechnology, growing at 30-35% annually and becoming the 12th largest destination globally.
- The sector has grown from a small beginning 25 years ago when the Department of Biotechnology was established, to over 400 companies today employing hundreds of thousands.
- Indian biotech companies have developed drugs for diseases like cancer and diabetes and produce vaccines at significantly lower costs than international markets.
- The government has strongly supported the sector through funding, institutions, and a supportive regulatory environment. However, the regulatory process remains complex.
- India has strengths in human resources
Hi all, with the rigorous secondary research for almost one month helped me to understand basic things about biosimilars and made me do this presentation. Hope u will appreciate it while going through it. thanks.
If anyone in need of this presentation, pls.put ur emial ID in comment box. will be sharing. and please share your thoughts about the presentation. i will be more thankful.
The document provides an overview of the pharmaceutical industry in India. It discusses the current state and growth of the industry. Some of the key points include:
- The Indian pharmaceutical industry is large and growing at 8-9% annually, currently worth $4.5 billion.
- Major players in the industry include Cipla, Ranbaxy, Dr. Reddy's, Sun Pharma, and Aurobindo Pharma.
- The government has introduced several initiatives to support the industry such as allowing 100% FDI and establishing a $639 million venture capital fund.
- The industry faces challenges of declining R&D productivity, patent expirations, and pricing issues but is expected
Biotechnology is the application of biological processes and systems to solve problems or make useful products. It includes techniques like genetic engineering, cloning, and cell fusion. India has emerged as a major player in biotechnology, with several top companies and research institutions. The future of biotechnology looks promising, with potential applications in medicine, agriculture, and more.
Biotechnology is the application of biological processes and systems to solve problems or make useful products. It includes techniques like genetic engineering, cloning, and cell fusion. India has emerged as a major player in biotechnology, with several biotech clusters and top companies located in cities like Bangalore, Hyderabad, and New Delhi. The Indian government has supported biotechnology growth through agencies and funding. Biotechnology is applied in diverse fields like healthcare, agriculture, industry, and environment.
The document provides 6 questions and their solutions related to applications of biotechnology. It discusses topics like induced pluripotent stem cells, Biotechnology Innovation Organization, applications of gene therapy, orphan drugs, bioprospecting, and the Human Genome Project. The questions aim to test the reader's understanding of these concepts and recent developments in biotechnology.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It was founded by Anji Reddy and currently has over 16,000 employees. The company started by producing active pharmaceutical ingredients and launched its first branded drug, Norilet, in 1986. It has since expanded internationally and focuses on both generics and research and development of new drugs. Dr. Reddy's engages in partnerships for research and development and works to provide affordable medicines globally through strategic suppliers. It also focuses on corporate social responsibility programs in education and livelihood advancement.
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
The document provides information on the group members and operations of Johnson & Johnson. It lists Priyanka Gujral as CEO and VP Legal, and others in VP roles for Communications, Marketing, and Strategy. It then summarizes that Johnson & Johnson was launched in 1886, is a large consumer health and pharmaceutical company operating in over 60 countries, and is headquartered in New Jersey. The document also lists the company's focus on research, innovation, and commitment to better living through various product categories and brands.
Presentation on Pharmaceutical sectors In BangladeshMD Juboraj
10 South Colonnade, Canary Wharf, London, E14 4PU
Employees: 1,500
Annual budget: £100 million
Website: www.gov.uk/mhra
Parent organization: Department of Health and Social Care
Awards: None
Mission: To ensure medicines and medical devices work and are acceptably safe.
Jurisdiction: United Kingdom
Key people: Dr. June Raine, Chief Executive
Customer service: 020 3080 6000
Email: info@mhra.gov.uk
Kiran Mazumdar-Shaw is an Indian entrepreneur who is the founder and chairperson of Biocon Limited, a biotechnology company based in Bangalore, India. She studied fermentation science and became the first woman to earn a degree in brewing. When she was unable to find work in her field in India due to gender discrimination, she started her own company Biocon in 1978 with just $500. Under her leadership, Biocon has grown into a major biotechnology company with over $800 million in annual revenue and has helped advance India's biotechnology industry. She has also established healthcare and education programs through the Biocon Foundation to benefit the underprivileged in India.
Kiran Mazumdar Shaw founded Biocon in 1978 in Bangalore as India's first biotech company. Starting with just two employees and operating out of a rented house garage with an initial capital of Rs. 10,000, Biocon focused initially on producing enzymes for use in industries like brewing. In the 1990s, Shaw pivoted Biocon's focus to biopharmaceuticals as its main business. Under her leadership, Biocon has grown to become a major biopharmaceutical company in India with facilities for producing insulin and statins. It has also expanded into areas like research services. Shaw's entrepreneurship and leadership has been instrumental in the growth of India's biotech sector.
Kiran Mazumdar Shaw is an Indian entrepreneur who founded Biocon, India's largest biotechnology company. After completing her education in zoology, she moved to Ireland and joined Biocon Biochemicals Limited as a trainee manager in 1978. In 1979, she founded Biocon India in collaboration with Biocon Biochemicals. Starting from her garage with only a few rupees, Biocon grew to become a major biopharmaceutical company under Kiran's leadership, pioneering the development of biosimilars and enzymes in India. Biocon now offers a range of biopharmaceuticals, enzymes, and clinical research services. Kiran is recognized for transforming Biocon into a globally recognized biotech company through her
Kallam Anji Reddy was an Indian industrialist and entrepreneur who founded Dr. Reddy's Laboratories in 1984. He transformed India's pharmaceutical industry from import-dependent to self-reliant and export-oriented. Reddy received many awards for his entrepreneurship and innovation. He was also a philanthropist who established the Dr. Reddy's Foundation for social development. Reddy passed away in 2013 at the age of 72, having made significant contributions to making medicines more affordable and accessible in India.
The Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US, and 25% of medicine in the UK. It is dominated by small and medium enterprises, though the largest 250 companies control 70% of the Indian market. India has gained prominence as the pharmacy of the world and biggest generic supplier due to its innovatively engineered generic drugs and active pharmaceutical ingredients. It accounts for around 30% of the $70-80 billion US generics market by volume and 10% by value.
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersDr. Pavan Kundur
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers,
Here i tried to compile all the future opportunities in biotechnology and microbiology
List of Nutraceutical Manufacturers in India | PharmaaddaAditiMehra14
The document lists the top 9 nutraceutical manufacturers in India and provides brief descriptions of each. It begins by defining nutraceuticals as products that provide both nutrition and medicinal benefits. Some of the largest manufacturers include Bionova Lifesciences, Chaitanya Agrobiotech Group, Lactonova Nutripharm, and Sydler. The industry in India is growing as multinational companies establish production facilities and Indian companies develop proprietary formulations to meet increasing demand for nutraceutical products.
Biotechnology has been used for thousands of years to produce foods and materials through fermentation and selective breeding. Modern biotechnology began in the 1970s with genetic engineering techniques allowing manipulation of organisms at the molecular level. While biotechnology has benefits like producing lifesaving drugs and drought-resistant crops, it also raises ethical issues regarding genetic modification and patenting of life. Governments aim to balance biotechnology development with responsible social and environmental oversight to ensure its safe and equitable progress.
Herbs, Herbal Drugs
Present Scope of Herbal Drug Industry
Scope of Herbal Drug Medicine and Industry
Indian Herbal Industry
International Scope of Herbal Medicines
World Wide Herbal Trade
Overview on plant based industries and research institutions in India
List of few herbal drug industries in India
List of few herbal research institution/ centres in India
General Introduction to Herbal Industry
Herbal drugs industry: Present scope and future prospects.
A brief account of plant based industries and institutions involved in work on medicinal and
aromatic plants in India.
The document discusses various topics related to biotechnology and biomedicine from a global perspective. It provides an overview of biotechnology applications, major biotechnology companies worldwide with the US dominating, and achievements in biotechnology in countries like India, China, and the US. It also summarizes developments in areas like medical biotechnology, biomedical engineering, genomics, tissue engineering, and future directions of biomedicine involving concepts like lab-on-a-chip and nanosensors.
The document discusses the evolution and growth of India's biotechnology sector. Some key points:
- India has emerged as a dominant player in biotechnology, growing at 30-35% annually and becoming the 12th largest destination globally.
- The sector has grown from a small beginning 25 years ago when the Department of Biotechnology was established, to over 400 companies today employing hundreds of thousands.
- Indian biotech companies have developed drugs for diseases like cancer and diabetes and produce vaccines at significantly lower costs than international markets.
- The government has strongly supported the sector through funding, institutions, and a supportive regulatory environment. However, the regulatory process remains complex.
- India has strengths in human resources
Hi all, with the rigorous secondary research for almost one month helped me to understand basic things about biosimilars and made me do this presentation. Hope u will appreciate it while going through it. thanks.
If anyone in need of this presentation, pls.put ur emial ID in comment box. will be sharing. and please share your thoughts about the presentation. i will be more thankful.
The document provides an overview of the pharmaceutical industry in India. It discusses the current state and growth of the industry. Some of the key points include:
- The Indian pharmaceutical industry is large and growing at 8-9% annually, currently worth $4.5 billion.
- Major players in the industry include Cipla, Ranbaxy, Dr. Reddy's, Sun Pharma, and Aurobindo Pharma.
- The government has introduced several initiatives to support the industry such as allowing 100% FDI and establishing a $639 million venture capital fund.
- The industry faces challenges of declining R&D productivity, patent expirations, and pricing issues but is expected
Biotechnology is the application of biological processes and systems to solve problems or make useful products. It includes techniques like genetic engineering, cloning, and cell fusion. India has emerged as a major player in biotechnology, with several top companies and research institutions. The future of biotechnology looks promising, with potential applications in medicine, agriculture, and more.
Biotechnology is the application of biological processes and systems to solve problems or make useful products. It includes techniques like genetic engineering, cloning, and cell fusion. India has emerged as a major player in biotechnology, with several biotech clusters and top companies located in cities like Bangalore, Hyderabad, and New Delhi. The Indian government has supported biotechnology growth through agencies and funding. Biotechnology is applied in diverse fields like healthcare, agriculture, industry, and environment.
The document provides 6 questions and their solutions related to applications of biotechnology. It discusses topics like induced pluripotent stem cells, Biotechnology Innovation Organization, applications of gene therapy, orphan drugs, bioprospecting, and the Human Genome Project. The questions aim to test the reader's understanding of these concepts and recent developments in biotechnology.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It was founded by Anji Reddy and currently has over 16,000 employees. The company started by producing active pharmaceutical ingredients and launched its first branded drug, Norilet, in 1986. It has since expanded internationally and focuses on both generics and research and development of new drugs. Dr. Reddy's engages in partnerships for research and development and works to provide affordable medicines globally through strategic suppliers. It also focuses on corporate social responsibility programs in education and livelihood advancement.
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
The document provides information on the group members and operations of Johnson & Johnson. It lists Priyanka Gujral as CEO and VP Legal, and others in VP roles for Communications, Marketing, and Strategy. It then summarizes that Johnson & Johnson was launched in 1886, is a large consumer health and pharmaceutical company operating in over 60 countries, and is headquartered in New Jersey. The document also lists the company's focus on research, innovation, and commitment to better living through various product categories and brands.
Presentation on Pharmaceutical sectors In BangladeshMD Juboraj
10 South Colonnade, Canary Wharf, London, E14 4PU
Employees: 1,500
Annual budget: £100 million
Website: www.gov.uk/mhra
Parent organization: Department of Health and Social Care
Awards: None
Mission: To ensure medicines and medical devices work and are acceptably safe.
Jurisdiction: United Kingdom
Key people: Dr. June Raine, Chief Executive
Customer service: 020 3080 6000
Email: info@mhra.gov.uk
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineCIOWomenMagazine
In this article, we will dive into the extraordinary life of Ellen Burstyn, where the curtains rise on a story that's far more attractive than any script.
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...BBPMedia1
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Final ank Satta Matka Dpbos Final ank Satta Matta Matka 143 Kalyan Matka Guessing Final Matka Final ank Today Matka 420 Satta Batta Satta 143 Kalyan Chart Main Bazar Chart vip Matka Guessing Dpboss 143 Guessing Kalyan night
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This presentation is a curated compilation of PowerPoint diagrams and templates designed to illustrate 20 different digital transformation frameworks and models. These frameworks are based on recent industry trends and best practices, ensuring that the content remains relevant and up-to-date.
Key highlights include Microsoft's Digital Transformation Framework, which focuses on driving innovation and efficiency, and McKinsey's Ten Guiding Principles, which provide strategic insights for successful digital transformation. Additionally, Forrester's framework emphasizes enhancing customer experiences and modernizing IT infrastructure, while IDC's MaturityScape helps assess and develop organizational digital maturity. MIT's framework explores cutting-edge strategies for achieving digital success.
These materials are perfect for enhancing your business or classroom presentations, offering visual aids to supplement your insights. Please note that while comprehensive, these slides are intended as supplementary resources and may not be complete for standalone instructional purposes.
Frameworks/Models included:
Microsoft’s Digital Transformation Framework
McKinsey’s Ten Guiding Principles of Digital Transformation
Forrester’s Digital Transformation Framework
IDC’s Digital Transformation MaturityScape
MIT’s Digital Transformation Framework
Gartner’s Digital Transformation Framework
Accenture’s Digital Strategy & Enterprise Frameworks
Deloitte’s Digital Industrial Transformation Framework
Capgemini’s Digital Transformation Framework
PwC’s Digital Transformation Framework
Cisco’s Digital Transformation Framework
Cognizant’s Digital Transformation Framework
DXC Technology’s Digital Transformation Framework
The BCG Strategy Palette
McKinsey’s Digital Transformation Framework
Digital Transformation Compass
Four Levels of Digital Maturity
Design Thinking Framework
Business Model Canvas
Customer Journey Map
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Niswey
50 million companies worldwide leverage WhatsApp as a key marketing channel. You may have considered adding it to your marketing mix, or probably already driving impressive conversions with WhatsApp.
But wait. What happens when you fully integrate your WhatsApp campaigns with HubSpot?
That's exactly what we explored in this session.
We take a look at everything that you need to know in order to deploy effective WhatsApp marketing strategies, and integrate it with your buyer journey in HubSpot. From technical requirements to innovative campaign strategies, to advanced campaign reporting - we discuss all that and more, to leverage WhatsApp for maximum impact. Check out more details about the event here https://events.hubspot.com/events/details/hubspot-new-delhi-presents-unlocking-whatsapp-marketing-with-hubspot-integrating-messaging-into-your-marketing-strategy/
Discover the Beauty and Functionality of The Expert Remodeling Serviceobriengroupinc04
Unlock your kitchen's true potential with expert remodeling services from O'Brien Group Inc. Transform your space into a functional, modern, and luxurious haven with their experienced professionals. From layout reconfiguration to high-end upgrades, they deliver stunning results tailored to your style and needs. Visit obriengroupinc.com to elevate your kitchen's beauty and functionality today.
Prescriptive analytics BA4206 Anna University PPTFreelance
Business analysis - Prescriptive analytics Introduction to Prescriptive analytics
Prescriptive Modeling
Non Linear Optimization
Demonstrating Business Performance Improvement
Profiles of Iconic Fashion Personalities.pdfTTop Threads
The fashion industry is dynamic and ever-changing, continuously sculpted by trailblazing visionaries who challenge norms and redefine beauty. This document delves into the profiles of some of the most iconic fashion personalities whose impact has left a lasting impression on the industry. From timeless designers to modern-day influencers, each individual has uniquely woven their thread into the rich fabric of fashion history, contributing to its ongoing evolution.
1. Innovation to Commercialization:
Our Role Models
Prabhat Arya
Prepared for the Meeting, “Business Opportunities in Life Sciences”
Modern College of Arts, Science and Commerce,
1
Pune, January 28, 2012
6. Dr. Yusuf Hamied, Chairman, Cipla Ltd.
Founded in 1935, Cipla makes drugs to treat
cardiovascular disease, arthritis, diabetes,
weight control, depression and many other
health conditions, and its products are
distributed in more than 180 countries
worldwide.
Revenue
Cipla is best-known outside its home country
US$1.09 billion for manufacturing low-cost anti-AIDS drugs
for HIV-positive patients in developing
Net income countries.
US$ 205.69 million (2010)
Founded by nationalist Indian scientist
Employees Khwaja Abdul Hamied.
16000
6
7. Cipla Ltd. – A Brief History
Khwaja Abdul
Hamied, the
founder of Cipla,
(born on October
31, 1898).
Mahatma Gandhi Visit to Cipla, July 4, 1939
7
8. Cipla is the world's largest
manufacturer of antiretroviral drug
(ARVs) to fight HIV/AIDS as measured
by units produced and distributed.
Roughly 40 percent of HIV/AIDS
patients undergoing antiretroviral
therapy worldwide take Cipla drugs.
Cipla reduced the cost of providing
antiretrovirals to AIDS patients from
$12,000 and beyond (monopoly prices
charged by international pharma
conglomerates) down to under $100
per year.
8
9. Dr. Kiran Mazumdar Shaw, Biocon
Born on March 23, 1953 in Bangalore, India
Mazumdar-Shaw completed her schooling
from the city’s Bishop Cotton Girl’s High
School (1968). She did BSc Zoology
Honours course from Mount Carmel College,
Bangalore University (1973). She later did
her post-graduation in Malting and Brewing
from Ballarat College, Melbourne University
(1975).
Net worth She worked as a trainee brewer in Carlton
and United Breweries, Melbourne and as a
US$900 million (2010) trainee maltster at Barrett Brothers and
Burston, Australia.
9
10. Biocon
In 1989, Biocon became the first Indian biotech company to receive US
funding for proprietary technologies. In 1990, she upgraded Biocon’s in-
house research program, based on a proprietary solid substrate
fermentation technology.
In 2007-08, a leading US trade publication, Med Ad News, ranked
Biocon as the 20th leading biotechnology companies in the world and
the 7th largest biotech employer in the world. Biocon also received the
2009 BioSingapore Asia Pacific Biotechnology Award for Best Listed
Company.
Biocon is building cutting-edge capabilities, global credibility and global
scale in its manufacturing and marketing activities. It has Asia’s largest
insulin and statin facilities as also the largest perfusion-based antibody
production facilities.
10
11. She started Biocon in 1978 and spearheaded its
evolution from an industrial enzymes manufacturing
company to a fully integrated bio-pharmaceutical
company with a well-balanced business portfolio of
products and a research focus on diabetes, oncology
and auto-immune diseases.
She also established two subsidiaries: Syngene (1994)
to provide development support services for discovery
research and Clinigene (2000) to cater to clinical
development services.
She was recently named among TIME magazine’s 100
most influential people in the world.
She is on the Forbes list of the world’s 100 most
powerful women and the Financial Times’ top 50 women
in business list.
11
12. Philanthropic Activities
Biocon Foundation (2004-) to conduct health, education, sanitation, and
environmental programs to benefit of the economically weaker sections of
society.
The Biocon Foundation's 7 ARY clinics are located where healthcare
facilities are poor and they offer clinical care, generic medicines and basic
tests for those who cannot afford them.
Each of the clinics serves a population of 50,000 people living within a
radius of 10 km. Each year, the Foundation touches more than 300,000
lives through its holistic healthcare approach.
Established a 1,400-bed cancer care center at the Narayana Health City
campus at Boommasandra, Bangalore, along with Dr. Devi Shetty of
Narayana Hrudayalaya in 2007.
12
13. Dr. Kallam Anji Reddy, Chairman, Dr. Reddy’s Labs
Dr. Reddy's Laboratories Ltd. is an integrated
pharmaceutical company focused on providing
medicines through its three business segments:
Global Generics segment, Pharmaceutical
Services and Active Ingredients (PSAI) segment
and Proprietary Products segment.
The company was founded by Dr. Anji Reddy,
who had previously worked in the publicly owned
Indian Drugs and Pharmaceuticals Limited of
Revenue
Hyderabad, India.
$1.67 billion (2011)
Dr. Reddy's manufactures and markets a wide
Net income
range of pharmaceuticals in India and overseas.
$248 million (2010)
The company has over 190 medications, 60
Employees
active pharmaceutical ingredients (APIs) for drug
14,923 (2010)
manufacture, diagnostic kits, critical care, and
biotechnology products. 13
14. Early Life and Education
Dr. Reddy spent his early years in the village of near suryapet nalgonda
in nalgonda District, where his father grew turmeric.
He studied in Anapothana ZPHS School in Nutakki until Tenth Class.
Dr. Reddy after graduating from the local high school, went on to get his
first Bachelor of science degree from A.C. College at Guntur in 1958.
Thereafter he, did his B.Sc.-Tech in Pharmaceuticals and Fine chemicals
from Bombay University followed by a Ph.D. in chemical engineering
from the National Chemical Laboratory, Pune in 1969.
14
15. Dr. Reddy started his career in the state-owned PSU, Indian
Drugs and Pharmaceuticals Limited (IDPL) (1969–1975).
Started Dr Reddy's Labs in 1984 with an initial capital of Rs
25 lakh (Rs 2.5 million).
Over the years, it transformed Indian bulk drug industry from
import-dependent in mid-80s to self-reliant in mid-90s and
finally into the export-oriented industry.
15
16. Investment in R&D
Dr. Reddy's Research Foundation was established in 1992 and
dedicated to research in area of new drug discovery.
In 2000, the Foundation set up an American lab in Atlanta,
dedicated to discovery and design of novel therapeutics.
The lab is called Reddy US Therapeutics Inc (RUSTI) and its
main aim is the discovery of next-generation drugs using
genomics and proteomics.
Reddy's research thrust focused on large niche areas in
western markets – anti-cancer, anti-diabetes, cardiovascular
and anti-infection drugs.
16
17. Philanthropic Activities
Naandi Foundation, a not-for-profit development
institution that strives for eradication of poverty
has Dr Reddy as its founding father. He is also
founder-chairman of Dr Reddy’s Foundation for
Human and Social Development, a social arm of
Dr. Reddy’s Labs.
17
18. Dr. A. V. Rama Rao:
From Scientist to Entreprenur
Recognized institutional builder and respected scientist with
over 35 years experience in research and leadership. Former
director of the Indian Institute of Chemical Technology (IICT) -
managing over 1,400 employees including 500 scientists
18
19. Born on the 2nd of April, 1935 in the city of Guntur,
Andhra Pradesh, India.
Degree in chemistry in 1956 from Andhra University and
postgraduate degree in Chemical Technology from
Bombay University in 1960.
Obtained his Ph.D. (Tech.) under the supervision of Prof.
Venkataraman, the first Indian Director of National
Chemical Laboratory, Pune.
19
20. Post-doctoral Studies with Prof. E. J. Corey (1991 Nobel
Laureate) at Harvard University.
After spending two years in E.J Corey’s group
(1975-’77), he returned to NCL and established a school of
excellence for the synthesis of bio-functional molecules
in India.
What Corey has to say About Dr. Rama Rao:
“your superb role as a leader of chemical synthesis in India is
well-known and much admired”
20
21. Dr. Rama Rao’s contribution to chemistry and medicine
emerges from his studies on natural products and organic
synthesis, and is spread over 250 research papers and
several patents.
Trained 109 graduate students for their Ph.D degrees and
several post-doctoral fellows.
He is responsible for initiating process chemistry in India and
giving a fillip to the Indian Pharma industry in producing
several life saving drugs at affordable prices.
21
22. Dr. Rama Rao initiated work on AZT (Azidothymidine), the first curative
agent for AIDS, and came out with an innovative and cost-effective
approach that was used by CIPLA in introducing the drug in India at a
cost of $0.30 per capsule against the international price of $3.0
22
23. Dr. S. K. Joshi, Former Director General, CSIR, states,
“Today the drug industry has a firm base of indigenous
production and has made a mark in export markets; much of
credit directly or indirectly goes to Dr. Rama Rao.
He is the man with the ‘Midas touch’ who transforms any drug
process development project to a roaring commercial
success.”
23
24. Dr. Rama Rao has proved to be an outstanding scientific
administrator too. Under his leadership (1985-
1995) IICT emerged as CSIR’s most reputed institution in
chemical sciences and technology.
Sir John Madox, Editor, “Nature” (Nature 366,626, Dec. 16th
1993) wrote thus: ‘‘the most improved laboratory in India must
be the Indian Institute of Chemical Technology at Hyderabad.
The difference is not so much the change of name,
but the arrival as Director of Dr. Rama Rao, a vigorous no-
nonsense organic chemist of distinction.”
24
25. Dr. Rama Rao spurred on by his unending zest for research in
science and technology and his keenness to cater to the needs
of pharmaceutical companies, went on to utilize these facilities
fruitfully and established AVRA Laboratories.
25
26. Dr. Rama Rao is probably the most outstanding
‘technopreneur’ India has produced in the post-
independent era with the unusual combination of
world class academic excellence, skills in developing
globally competitive technologies and
entrepreneurship in setting up a flourishing
knowledge-based industry.
26
32. Professor Gordon Shore
Department of Biochemistry
McGill University, Montreal,
Canada
Regulation of oncogene-induced
apoptosis
PhD (1974), McGill University
32
34. GeminX Pharmaceuticals specializes in the discovery and development
of novel small-molecule cancer therapeutics based on the regulation of
apoptosis, the body’s natural ability to destroy injured or damaged cells.
GeminX’s lead product, GX15-070, is a small-molecule, pan-inhibitor of
Bcl-2 proteins.
GeminX is also developing small molecules that induce apoptosis in p53-
defective cancers.
34
35. Cephalon to Acquire Gemin X for $225M
(march 2011)
Cephalon Inc. said on Monday it will acquire privately held Gemin X
Pharmaceuticals Inc. for $225 million in an all-cash deal aimed at
bolstering Cephalon's lineup of cancer treatments.
Cephalon said Gemin X's private shareholders could receive as much as
an additional $300 million in cash payments if certain regulatory and sales
goals are met.
Cephalon would have no royalty obligations to Gemin X shareholders
under the transaction, which is subject to regulatory clearances and other
conditions. After the deal's expected closure in this year's second quarter,
Gemin X would become a wholly owned subsidiary of Cephalon.
35
36. Taxol Natural Product as Anti Cancer Drug
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was
discovered in a U.S. National Cancer Institute program at the Research
Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani
isolated it from the bark of the Pacific yew tree, Taxus brevifolia and
named it taxol. When it was developed commercially by Bristol-Myers
Squibb (BMS) the generic name was changed to paclitaxel and the BMS
compound is sold under the trademark TAXOL.
36
39. Taxol Journey ...by Christmas
of 1966 Wall was
calling for 375
pounds of
bark....for every
30 pounds he
got, he was
producing barely
half a gram of
Botanist Arthur Barclay K172.
in hat, records a plant
collection in the field,
early 1960s.
World Beaters: A happy team of FSU
Taxol researchers led by Bob Holton
claimed victory in totally synthesizing
the drug on Dec. 9, 1993.
39
40. Hope in a Bottle: Bristol-Myers
Squibb introduced Taxol to the
market place in January 1993.
From bark to business, the
process took 31 years.
40
41. Professor Y Kishi, Chem and Chem Biol,
Harvard University
Halichondrin B
41
Nature, 468, Dec 2 Issue 2010, 609-610
47. Support of the Broad Institute
Eli and Edythe L. Broad: $100M (over ten years)
(doubled in a short duration)
Sept 2008, Declared this Institute Model a Success
Eli and Edythe L. Broad: $400M
The Stanley Medical Research Institute: The Stanley
Center for Psychiatric Research was created in 2007
Support: $100M over ten years
47